NZ220100A - Benzothiazinones as calcium antagonists - Google Patents
Benzothiazinones as calcium antagonistsInfo
- Publication number
- NZ220100A NZ220100A NZ220100A NZ22010087A NZ220100A NZ 220100 A NZ220100 A NZ 220100A NZ 220100 A NZ220100 A NZ 220100A NZ 22010087 A NZ22010087 A NZ 22010087A NZ 220100 A NZ220100 A NZ 220100A
- Authority
- NZ
- New Zealand
- Prior art keywords
- benzothiazinones
- calcium antagonists
- antagonists
- calcium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863614363 DE3614363A1 (en) | 1986-04-28 | 1986-04-28 | BENZOTHIAZINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ220100A true NZ220100A (en) | 1990-03-27 |
Family
ID=6299713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ220100A NZ220100A (en) | 1986-04-28 | 1987-04-27 | Benzothiazinones as calcium antagonists |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0244723A3 (en) |
JP (1) | JPS62258371A (en) |
KR (1) | KR870010028A (en) |
AU (1) | AU601659B2 (en) |
DE (1) | DE3614363A1 (en) |
DK (1) | DK213387A (en) |
FI (1) | FI871813A (en) |
HU (1) | HU199814B (en) |
IL (1) | IL82332A (en) |
NO (1) | NO871745L (en) |
NZ (1) | NZ220100A (en) |
PT (1) | PT84770B (en) |
ZA (1) | ZA872972B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3724366A1 (en) * | 1987-07-23 | 1989-02-02 | Hoechst Ag | BENZOTHIAZINONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF |
DE3726759A1 (en) * | 1987-08-12 | 1989-03-09 | Hoechst Ag | BENZOTHIAZINONE OXIDES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING IT AND THEIR USE, AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION |
US5182276A (en) * | 1989-06-16 | 1993-01-26 | Santen Pharmaceutical Co., Ltd. | Nootropic agent |
US6207665B1 (en) | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
US6693099B2 (en) * | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
BRPI0404222A (en) * | 2004-06-07 | 2006-02-07 | Fundacao Oswaldo Cruz | Lidocaine derivatives, pharmaceutical compositions containing them, use of the respective pharmaceutical compositions in the treatment, prevention or inhibition of diseases as well as the method of treating, preventing or inhibiting diseases with said pharmaceutical compositions |
JP6836502B2 (en) * | 2014-05-30 | 2021-03-03 | スプハエラ ファーマ ピーヴィーティー リミテッド | New compound as an anti-tuberculosis drug |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59148771A (en) * | 1983-02-09 | 1984-08-25 | Santen Pharmaceut Co Ltd | Benzothiazine derivative |
US4584300A (en) * | 1983-02-07 | 1986-04-22 | Santen Pharmaceutical Co., Ltd. | Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor |
DE3347173A1 (en) * | 1983-12-27 | 1985-07-04 | Hoechst Ag, 6230 Frankfurt | NEW BENZOTHIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF |
EP0186310A1 (en) * | 1984-11-28 | 1986-07-02 | Takeda Chemical Industries, Ltd. | 1,4-Benzothiazine Derivatives, their production and use |
EP0233291B1 (en) * | 1985-03-19 | 1991-03-13 | Santen Pharmaceutical Co., Ltd. | 2-arylbenzothiazine derivatives |
US4786635A (en) * | 1985-07-29 | 1988-11-22 | Santen Pharmaceutical Co., Ltd. | Novel benzothiazine derivatives |
-
1986
- 1986-04-28 DE DE19863614363 patent/DE3614363A1/en not_active Withdrawn
-
1987
- 1987-04-24 FI FI871813A patent/FI871813A/en not_active Application Discontinuation
- 1987-04-25 EP EP87106067A patent/EP0244723A3/en not_active Withdrawn
- 1987-04-27 DK DK213387A patent/DK213387A/en not_active Application Discontinuation
- 1987-04-27 NO NO871745A patent/NO871745L/en unknown
- 1987-04-27 KR KR870004045A patent/KR870010028A/en not_active Application Discontinuation
- 1987-04-27 HU HU871845A patent/HU199814B/en not_active IP Right Cessation
- 1987-04-27 IL IL82332A patent/IL82332A/en unknown
- 1987-04-27 PT PT84770A patent/PT84770B/en not_active IP Right Cessation
- 1987-04-27 ZA ZA872972A patent/ZA872972B/en unknown
- 1987-04-27 JP JP62102143A patent/JPS62258371A/en active Pending
- 1987-04-27 AU AU71994/87A patent/AU601659B2/en not_active Ceased
- 1987-04-27 NZ NZ220100A patent/NZ220100A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU601659B2 (en) | 1990-09-13 |
PT84770B (en) | 1989-12-29 |
AU7199487A (en) | 1987-10-29 |
FI871813A (en) | 1987-10-29 |
DE3614363A1 (en) | 1987-10-29 |
KR870010028A (en) | 1987-11-30 |
PT84770A (en) | 1987-05-01 |
JPS62258371A (en) | 1987-11-10 |
DK213387A (en) | 1987-10-29 |
ZA872972B (en) | 1987-11-25 |
DK213387D0 (en) | 1987-04-27 |
EP0244723A2 (en) | 1987-11-11 |
NO871745L (en) | 1987-10-29 |
NO871745D0 (en) | 1987-04-27 |
HUT45517A (en) | 1988-07-28 |
HU199814B (en) | 1990-03-28 |
IL82332A (en) | 1991-08-16 |
EP0244723A3 (en) | 1988-10-19 |
IL82332A0 (en) | 1987-10-30 |
FI871813A0 (en) | 1987-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0270947A3 (en) | Substituted basic 2-aminotetralines | |
IL83589A0 (en) | Substituted benzoylphenyl-ureas | |
ZA874769B (en) | Calcium salts | |
AP8700055A0 (en) | Substituted indoloquino xalines | |
ZA876302B (en) | Substituted 1-aryl-3-tert.-butyl-pyrazoles | |
ZA872433B (en) | Substituted aminoxy-propanoates | |
GB8631004D0 (en) | Anchoring | |
AR243502A1 (en) | Certain substituted 3-amino-2-benzoylcyclohex-2-enones | |
NZ220100A (en) | Benzothiazinones as calcium antagonists | |
GR861165B (en) | Dihydropyridine calcium antagonists | |
ZA872432B (en) | Substituted aminoxy-propionamides | |
ZA894755B (en) | Lactamimides as calcium antagonists | |
ZA879548B (en) | Substituted n-methylisoxazolidines | |
GB2187739B (en) | Substituted pyrimidoindoles | |
ZA879546B (en) | Substituted phenoxypyridines | |
ZA883601B (en) | Vaspressin antagonists | |
IE892087L (en) | Lactamimides as calcium antagonists | |
GB8614246D0 (en) | Substituted pyrimidoindoles | |
ZA877869B (en) | Substituted amino-ketals | |
IE861178L (en) | Dihydropyridine calcium antagonists. | |
ZA90841B (en) | Calcium antagonists | |
ZA879254B (en) | Substituted basic 2-aminotetralins | |
CS403786A1 (en) | Portlandsky cement so zvysenymi pociatocnymi pevnostami | |
CS403886A1 (en) | Portlandsky cement so zvysenymi pociatocnymi pevnostami | |
CS403686A1 (en) | Portlandsky alebo struskoportlandsky cement so zvysenymi pociatocnymi pevnostami |